Cancer Medicines Forum workshop

Amsterdam, NL (Hybrid Event)

The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.

The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.

Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam

Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.

Next events

  • EORTC Pathobiology Group Spring Meeting

    Virtual Event

  • EORTC Head and Neck Cancer Group Spring Meeting

    Hamburg, DE

  • ESTRO 2024


  • EORTC Lung Cancer Group Spring Meeting

    Malaga, Spain

  • EORTC Gynecological Cancer Group Spring Meeting

    Barcelona, Spain